Alcon Q1 2023 Earnings Presentation

Q1 2023 Cash flow and balance sheet highlights Cash and cash equivalents $889 million 1Q23 cash flows from operations $85 million 1Q23 free cash flow' ($19) million Capex $104 million Investments in new contact lens manufacturing capacity Debt $4.7 billion No financial covenants Alcon 1. Free cash flow is a non-IFRS measure. An explanation of non-IFRS measures can be found in the Appendix. 16

View entire presentation